201 related articles for article (PubMed ID: 28414550)
1. Expression of Long Noncoding RNA Urothelial Cancer Associated 1 Promotes Cisplatin Resistance in Cervical Cancer.
Wang B; Huang Z; Gao R; Zeng Z; Yang W; Sun Y; Wei W; Wu Z; Yu L; Li Q; Zhang S; Li F; Liu G; Liu B; Leng L; Zhan W; Yu Y; Yang G; Zhou S
Cancer Biother Radiopharm; 2017 Apr; 32(3):101-110. PubMed ID: 28414550
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of long noncoding RNA urothelial cancer-associated 1 enhances cisplatin chemosensitivity in tongue squamous cell carcinoma cells.
Wang J; Li L; Wu K; Ge W; Zhang Z; Gong L; Yuan D
Pharmazie; 2016 Oct; 71(10):598-602. PubMed ID: 29441929
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells.
Pan J; Li X; Wu W; Xue M; Hou H; Zhai W; Chen W
Cancer Lett; 2016 Nov; 382(1):64-76. PubMed ID: 27591936
[TBL] [Abstract][Full Text] [Related]
4. Suppression of long noncoding RNA NCK1-AS1 increases chemosensitivity to cisplatin in cervical cancer.
Zhang WY; Liu YJ; He Y; Chen P
J Cell Physiol; 2019 Apr; 234(4):4302-4313. PubMed ID: 30221354
[TBL] [Abstract][Full Text] [Related]
5. Long non‑coding RNA urothelial cancer associated 1 regulates radioresistance via the hexokinase 2/glycolytic pathway in cervical cancer.
Fan L; Huang C; Li J; Gao T; Lin Z; Yao T
Int J Mol Med; 2018 Oct; 42(4):2247-2259. PubMed ID: 30015920
[TBL] [Abstract][Full Text] [Related]
6. Long Noncoding RNA GAS5, Which Acts as a Tumor Suppressor via microRNA 21, Regulates Cisplatin Resistance Expression in Cervical Cancer.
Wen Q; Liu Y; Lyu H; Xu X; Wu Q; Liu N; Yin Q; Li J; Sheng X
Int J Gynecol Cancer; 2017 Jul; 27(6):1096-1108. PubMed ID: 28472815
[TBL] [Abstract][Full Text] [Related]
7. Inhibiting the cytoplasmic location of HMGB1 reverses cisplatin resistance in human cervical cancer cells.
Xia J; Yu X; Song X; Li G; Mao X; Zhang Y
Mol Med Rep; 2017 Jan; 15(1):488-494. PubMed ID: 27959427
[TBL] [Abstract][Full Text] [Related]
8. Long Non-Coding RNA (LncRNA) Urothelial Carcinoma Associated 1 (UCA1) Increases Multi-Drug Resistance of Gastric Cancer via Downregulating miR-27b.
Fang Q; Chen X; Zhi X
Med Sci Monit; 2016 Oct; 22():3506-3513. PubMed ID: 27694794
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling.
Fan Y; Shen B; Tan M; Mu X; Qin Y; Zhang F; Liu Y
FEBS J; 2014 Apr; 281(7):1750-8. PubMed ID: 24495014
[TBL] [Abstract][Full Text] [Related]
10. The long non-coding RNA, urothelial carcinoma associated 1, promotes cell growth, invasion, migration, and chemo-resistance in glioma through Wnt/β-catenin signaling pathway.
Zhang B; Fang S; Cheng Y; Zhou C; Deng F
Aging (Albany NY); 2019 Oct; 11(19):8239-8253. PubMed ID: 31596734
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA UCA1 upregulates KIF20A expression to promote cell proliferation and invasion via sponging miR-204 in cervical cancer.
He Q; Meng J; Liu S; Zeng Q; Zhu Q; Wei Z; Shao Y
Cell Cycle; 2020 Oct; 19(19):2486-2495. PubMed ID: 32835591
[TBL] [Abstract][Full Text] [Related]
12. Expression of the lncRNA ZFAS1 in cervical cancer and its correlation with prognosis and chemosensitivity.
Feng LL; Shen FR; Zhou JH; Chen YG
Gene; 2019 May; 696():105-112. PubMed ID: 30738960
[TBL] [Abstract][Full Text] [Related]
13. Silence of long noncoding RNA UCA1 inhibits malignant proliferation and chemotherapy resistance to adriamycin in gastric cancer.
Shang C; Guo Y; Zhang J; Huang B
Cancer Chemother Pharmacol; 2016 May; 77(5):1061-7. PubMed ID: 27056384
[TBL] [Abstract][Full Text] [Related]
14. lncRNA-UCA1 enhances cell proliferation through functioning as a ceRNA of Sox4 in esophageal cancer.
Jiao C; Song Z; Chen J; Zhong J; Cai W; Tian S; Chen S; Yi Y; Xiao Y
Oncol Rep; 2016 Nov; 36(5):2960-2966. PubMed ID: 27667646
[TBL] [Abstract][Full Text] [Related]
15. lncRNA
Yang L; Zhang L; Lu L; Wang Y
DNA Cell Biol; 2020 Jan; 39(1):69-77. PubMed ID: 31702387
[TBL] [Abstract][Full Text] [Related]
16. Analysis of lncRNA UCA1-related downstream pathways and molecules of cisplatin resistance in lung adenocarcinoma.
Zhou H; Shen Q; Fu J; Jiang F; Wang L; Wang Y
J Clin Lab Anal; 2020 Aug; 34(8):e23312. PubMed ID: 32249461
[TBL] [Abstract][Full Text] [Related]
17. UCA1, a long non-coding RNA up-regulated in colorectal cancer influences cell proliferation, apoptosis and cell cycle distribution.
Han Y; Yang YN; Yuan HH; Zhang TT; Sui H; Wei XL; Liu L; Huang P; Zhang WJ; Bai YX
Pathology; 2014 Aug; 46(5):396-401. PubMed ID: 24977734
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of the Urothelial Cancer Associated 1 Long Noncoding RNA Promotes Proliferation of Vascular Smooth Muscle Cells by Modulating Expression of P27KIP1/CDK2.
Zheng HK; Dong MH; Liu GH; An Z; Zhang L; Shan RT; Zhang WQ
Genet Test Mol Biomarkers; 2020 Apr; 24(4):204-211. PubMed ID: 32213082
[No Abstract] [Full Text] [Related]
19. Long non-coding RNA UCA1 enhances tamoxifen resistance in breast cancer cells through a miR-18a-HIF1α feedback regulatory loop.
Li X; Wu Y; Liu A; Tang X
Tumour Biol; 2016 Nov; 37(11):14733-14743. PubMed ID: 27629141
[TBL] [Abstract][Full Text] [Related]
20. SPP1 inhibition improves the cisplatin chemo-sensitivity of cervical cancer cell lines.
Chen X; Xiong D; Ye L; Yang H; Mei S; Wu J; Chen S; Mi R
Cancer Chemother Pharmacol; 2019 Apr; 83(4):603-613. PubMed ID: 30627777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]